Post Operative Nausea And Vomiting ' Pipeline Review, H2 2012

Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!

Post Operative Nausea And Vomiting ' Pipeline Review, H2 2012
Published on August 2012

Report Summary


Summary

Global Markets Direct's, 'Post Operative Nausea And Vomiting - Pipeline Review, H2 2012', provides an overview of the Post
Operative Nausea And Vomiting therapeutic pipeline. This report provides information on the therapeutic development for Post
Operative Nausea And Vomiting, complete with latest updates, and special features on late-stage and discontinued projects. It also
reviews key players involved in the therapeutic development for Post Operative Nausea And Vomiting. 'Post Operative Nausea And
Vomiting - Pipeline Review, H2 2012' is built using data and information sourced from Global Markets Direct's proprietary databases,
Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and
industry-specific third party sources, put together by Global Markets Direct's team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated
disease.

Scope

- A snapshot of the global therapeutic scenario for Post Operative Nausea And Vomiting.
- A review of the Post Operative Nausea And Vomiting products under development by companies and universities/research institutes
based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Post Operative Nausea And Vomiting pipeline on the basis of route of administration and molecule type.
- Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development
progress.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.

Reasons to buy

- Identify and understand important and diverse types of therapeutics under development for Post Operative Nausea And Vomiting.
- Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive
advantage.
- Plan mergers and acquisitions effectively by identifying players with the most promising pipeline.
- Devise corrective measures for pipeline projects by understanding Post Operative Nausea And Vomiting pipeline depth and focus of
Post Operative Nausea And Vomiting therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to
enhance and expand business potential and scope.
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Post Operative Nausea And Vomiting ' Pipeline Review, H2 2012 (From Slideshare) Page 1/6


Table of Content

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Post Operative Nausea And Vomiting Overview 6
Therapeutics Development 7
An Overview of Pipeline Products for Post Operative Nausea And Vomiting 7
Post Operative Nausea And Vomiting Therapeutics under Development by Companies 9
Post Operative Nausea And Vomiting Therapeutics under Investigation by Universities/Institutes 10
Late Stage Products 11
Comparative Analysis 11
Mid Clinical Stage Products 12
Early Clinical Stage Products 13
Post Operative Nausea And Vomiting Therapeutics ' Products under Development by Companies 14
Post Operative Nausea And Vomiting Therapeutics ' Products under Investigation by Universities/Institutes 15
Companies Involved in Post Operative Nausea And Vomiting Therapeutics Development 16
GlaxoSmithKline plc 16
Axcan Pharma Inc. 17
Acacia Pharma Ltd. 18
Post Operative Nausea And Vomiting ' Therapeutics Assessment 19
Assessment by Monotherapy Products 19
Assessment by Route of Administration 20
Assessment by Molecule Type 22
Drug Profiles 24
Rolapitant - Drug Profile 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
EUR 1025 - Drug Profile 25
R&D Progress 25
Vestipitant - Drug Profile 26
R&D Progress 26
APD421 - Drug Profile 27
R&D Progress 27



Palonosetron - Drug Profile 28
R&D Progress 28
Post Operative Nausea And Vomiting Therapeutics ' Drug Profile Updates 29
Post Operative Nausea And Vomiting Therapeutics ' Discontinued Products 32
Post Operative Nausea And Vomiting Therapeutics - Dormant Products 33
Post Operative Nausea And Vomiting ' Product Development Milestones 34
Featured News & Press Releases 34
May 28, 2012: Acacia Pharma Announces Positive Results For APD421 In Post-Operative Nausea & Vomiting 34
Appendix 35
Methodology 35
Coverage 35
Secondary Research 35
Primary Research 35
Expert Panel Validation 35
Contact Us 36
Disclaimer 36

List of Tables

Number of Products Under Development for Post Operative Nausea And Vomiting, H2 2012 7
Products under Development for Post Operative Nausea And Vomiting ' Comparative Analysis, H2 2012 8
Number of Products under Development by Companies, H2 2012 9
Number of Products under Investigation by Universities/Institutes, H2 2012 10
Comparative Analysis by Late Stage Development, H2 2012 11
Comparative Analysis by Mid Clinical Stage Development, H2 2012 12
Comparative Analysis by Early Clinical Stage Development, H2 2012 13
Products under Development by Companies, H2 2012 14
Products under Investigation by Universities/Institutes, H2 2012 15
GlaxoSmithKline plc, H2 2012 16
Axcan Pharma Inc., H2 2012 17
Acacia Pharma Ltd., H2 2012 18
Assessment by Monotherapy Products, H2 2012 19
Assessment by Stage and Route of Administration, H2 2012 21
Assessment by Stage and Molecule Type, H2 2012 23
Post Operative Nausea And Vomiting Therapeutics ' Drug Profile Updates 29
Post Operative Nausea And Vomiting Therapeutics ' Discontinued Products 32
Post Operative Nausea And Vomiting Therapeutics ' Dormant Products 33

List of Figures

Number of Products under Development for Post Operative Nausea And Vomiting, H2 2012 7
Products under Development for Post Operative Nausea And Vomiting ' Comparative Analysis, H2 2012 8
Products under Development by Companies, H2 2012 9
Products under Investigation by Universities/Institutes, H2 2012 10
Late Stage Products, H2 2012 11
Mid Clinical Stage Products, H2 2012 12



Early Clinical Stage Products, H2 2012 13
Assessment by Monotherapy Products, H2 2012 19
Assessment by Route of Administration, H2 2012 20
Assessment by Stage and Route of Administration, H2 2012 21
Assessment by Molecule Type, H2 2012 22
Assessment by Stage and Molecule Type, H2 2012 23


Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
If you have any questions please visit http://www.reportlinker.com/notify/contact

Order Information
Please verify that the product information is correct and select the format(s) you require.


Product Formats
Please select the product formats and the quantity you require.

1 User License--USD 2 000.00 Quantity: _____

Site License--USD 4 000.00 Quantity: _____

Corporate License--USD 6 000.00 Quantity: _____

Contact Information
Please enter all the information below in BLOCK CAPITALS

Title: Mr Mrs Dr Miss Ms Prof

First Name: _____________________________ Last Name: __________________________________

Email Address: __________________________________________________________________________

Job Title: __________________________________________________________________________

Organization: __________________________________________________________________________

Address: __________________________________________________________________________

City: __________________________________________________________________________

Postal / Zip Code: __________________________________________________________________________

Country: __________________________________________________________________________

Phone Number: __________________________________________________________________________

Fax Number: __________________________________________________________________________


Payment Information
Please indicate the payment method, you would like to use by selecting the appropriate box.

Payment by credit card Card Number: ______________________________________________

Expiry Date __________ / _________

CVV Number _____________________

Card Type (ex: Visa, Amex…) _________________________________

Payment by wire transfer Crédit Mutuel
RIB : 10278 07314 00020257701 89
BIC : CMCIFR2A
IBAN : FR76 1027 8073 1400 0202 5770 189

Payment by check UBIQUICK SAS
16 rue Grenette – 69002 LYON, FRANCE

Customer signature:

Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at
http://www.reportlinker.com/index/terms

Please fax this form to:

Europe, Middle East and Africa : + 33 4 37 37 15 56

Asia, Oceania and America : + 1 (805) 617 17 93


Post Operative Nausea And Vomiting ' Pipeline Review, H2 2012

Recomendados

Recomendados

Mais conteúdo relacionado

Destaque

Destaque (15)

Mais de ReportLinker.com

Mais de ReportLinker.com (20)

Post Operative Nausea And Vomiting ' Pipeline Review, H2 2012